NEW YORK (GenomeWeb News) – WaferGen BioSystems said in a regulatory document that revenues for its first quarter more than doubled year over year.
It separately also announced a stock sale by shareholders of up to more than 112 million shares.
NEW YORK (GenomeWeb News) – Nanosphere today said that its first-quarter revenues jumped 85 percent year over year as consumables sales rose 123 percent.
The company also said that it secured $27 million in new financing.
Silence Therapeutics this week announced that it is closing in on a much-needed financial shot in the arm, inking deals to raise £18.7 million ($28.6 million) through the private placement of 9.5 million shares to certain investors.
NEW YORK (GenomeWeb News) – Atossa Genetics today said that revenues for 2012 increased sharply following the launch of two tests.
Separately, the company also said that it has entered into a $30 million stock purchase agreement with Aspire Capital.